Cargando…

Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study

Dysfunctional glutamatergic neurotransmission has been implicated in autism spectrum disorder (ASD). However, relatively few studies have directly measured brain glutamate in ASD adults, or related variation in glutamate to clinical phenotype. We therefore set out to investigate brain glutamate leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Horder, J, Lavender, T, Mendez, M A, O'Gorman, R, Daly, E, Craig, M C, Lythgoe, D J, Barker, G J, Murphy, D G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731785/
https://www.ncbi.nlm.nih.gov/pubmed/23838890
http://dx.doi.org/10.1038/tp.2013.53
_version_ 1782279197086973952
author Horder, J
Lavender, T
Mendez, M A
O'Gorman, R
Daly, E
Craig, M C
Lythgoe, D J
Barker, G J
Murphy, D G
author_facet Horder, J
Lavender, T
Mendez, M A
O'Gorman, R
Daly, E
Craig, M C
Lythgoe, D J
Barker, G J
Murphy, D G
author_sort Horder, J
collection PubMed
description Dysfunctional glutamatergic neurotransmission has been implicated in autism spectrum disorder (ASD). However, relatively few studies have directly measured brain glutamate in ASD adults, or related variation in glutamate to clinical phenotype. We therefore set out to investigate brain glutamate levels in adults with an ASD, comparing these to healthy controls and also comparing results between individuals at different points on the spectrum of symptom severity. We recruited 28 adults with ASD and 14 matched healthy controls. Of those with ASD, 15 fulfilled the ‘narrowly' defined criteria for typical autism, whereas 13 met the ‘broader phenotype'. We measured the concentration of the combined glutamate and glutamine signal (Glx), and other important metabolites, using proton magnetic resonance spectroscopy in two brain regions implicated in ASD—the basal ganglia (including the head of caudate and the anterior putamen) and the dorsolateral prefrontal cortex—as well as in a parietal cortex ‘control' region. Individuals with ASD had a significant decrease (P<0.001) in concentration of Glx in the basal ganglia, and this was true in both the ‘narrow' and ‘broader' phenotype. Also, within the ASD sample, reduced basal ganglia Glx was significantly correlated with increased impairment in social communication (P=0.013). In addition, there was a significant reduction in the concentration of other metabolites such as choline, creatine (Cr) and N-acetylaspartate (NAA) in the basal ganglia. In the dorsolateral prefrontal cortex, Cr and NAA were reduced (P<0.05), although Glx was not. There were no detectable differences in Glx, or any other metabolite, in the parietal lobe control region. There were no significant between-group differences in age, gender, IQ, voxel composition or data quality. In conclusion, individuals across the spectrum of ASD have regionally specific abnormalities in subcortical glutamatergic neurotransmission that are associated with variation in social development.
format Online
Article
Text
id pubmed-3731785
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-37317852013-08-02 Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study Horder, J Lavender, T Mendez, M A O'Gorman, R Daly, E Craig, M C Lythgoe, D J Barker, G J Murphy, D G Transl Psychiatry Original Article Dysfunctional glutamatergic neurotransmission has been implicated in autism spectrum disorder (ASD). However, relatively few studies have directly measured brain glutamate in ASD adults, or related variation in glutamate to clinical phenotype. We therefore set out to investigate brain glutamate levels in adults with an ASD, comparing these to healthy controls and also comparing results between individuals at different points on the spectrum of symptom severity. We recruited 28 adults with ASD and 14 matched healthy controls. Of those with ASD, 15 fulfilled the ‘narrowly' defined criteria for typical autism, whereas 13 met the ‘broader phenotype'. We measured the concentration of the combined glutamate and glutamine signal (Glx), and other important metabolites, using proton magnetic resonance spectroscopy in two brain regions implicated in ASD—the basal ganglia (including the head of caudate and the anterior putamen) and the dorsolateral prefrontal cortex—as well as in a parietal cortex ‘control' region. Individuals with ASD had a significant decrease (P<0.001) in concentration of Glx in the basal ganglia, and this was true in both the ‘narrow' and ‘broader' phenotype. Also, within the ASD sample, reduced basal ganglia Glx was significantly correlated with increased impairment in social communication (P=0.013). In addition, there was a significant reduction in the concentration of other metabolites such as choline, creatine (Cr) and N-acetylaspartate (NAA) in the basal ganglia. In the dorsolateral prefrontal cortex, Cr and NAA were reduced (P<0.05), although Glx was not. There were no detectable differences in Glx, or any other metabolite, in the parietal lobe control region. There were no significant between-group differences in age, gender, IQ, voxel composition or data quality. In conclusion, individuals across the spectrum of ASD have regionally specific abnormalities in subcortical glutamatergic neurotransmission that are associated with variation in social development. Nature Publishing Group 2013-07 2013-07-09 /pmc/articles/PMC3731785/ /pubmed/23838890 http://dx.doi.org/10.1038/tp.2013.53 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Original Article
Horder, J
Lavender, T
Mendez, M A
O'Gorman, R
Daly, E
Craig, M C
Lythgoe, D J
Barker, G J
Murphy, D G
Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study
title Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study
title_full Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study
title_fullStr Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study
title_full_unstemmed Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study
title_short Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study
title_sort reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)h]mrs study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731785/
https://www.ncbi.nlm.nih.gov/pubmed/23838890
http://dx.doi.org/10.1038/tp.2013.53
work_keys_str_mv AT horderj reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT lavendert reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT mendezma reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT ogormanr reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT dalye reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT craigmc reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT lythgoedj reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT barkergj reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy
AT murphydg reducedsubcorticalglutamateglutamineinadultswithautismspectrumdisordersa1hmrsstudy